Elizabeth Bayliss
Concepts (375)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deprescriptions | 16 | 2025 | 32 | 7.560 |
Why?
| | Chronic Disease | 32 | 2024 | 1807 | 4.040 |
Why?
| | Dementia | 12 | 2025 | 269 | 3.450 |
Why?
| | Multiple Chronic Conditions | 13 | 2025 | 32 | 2.980 |
Why?
| | Cognitive Dysfunction | 7 | 2024 | 416 | 2.660 |
Why?
| | Patient Portals | 5 | 2024 | 45 | 2.450 |
Why?
| | Primary Health Care | 23 | 2025 | 1757 | 2.300 |
Why?
| | Comorbidity | 23 | 2018 | 1671 | 2.160 |
Why?
| | Patient-Centered Care | 8 | 2021 | 539 | 1.850 |
Why?
| | Patient Care Team | 9 | 2019 | 667 | 1.690 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 4 | 2024 | 254 | 1.650 |
Why?
| | Polypharmacy | 8 | 2025 | 89 | 1.590 |
Why?
| | Aged | 71 | 2025 | 24836 | 1.480 |
Why?
| | Electronic Health Records | 8 | 2025 | 1129 | 1.400 |
Why?
| | Aged, 80 and over | 35 | 2025 | 7948 | 1.350 |
Why?
| | Potentially Inappropriate Medication List | 4 | 2024 | 16 | 1.310 |
Why?
| | Delivery of Health Care, Integrated | 6 | 2021 | 291 | 1.280 |
Why?
| | Health Status | 8 | 2019 | 822 | 1.270 |
Why?
| | Physicians, Primary Care | 7 | 2019 | 223 | 1.260 |
Why?
| | Quality of Life | 16 | 2022 | 3024 | 1.180 |
Why?
| | Safety-net Providers | 3 | 2021 | 124 | 1.130 |
Why?
| | Delivery of Health Care | 8 | 2021 | 948 | 1.090 |
Why?
| | Depressive Disorder | 4 | 2012 | 375 | 1.080 |
Why?
| | Continuity of Patient Care | 4 | 2019 | 282 | 1.040 |
Why?
| | Inappropriate Prescribing | 2 | 2024 | 59 | 1.040 |
Why?
| | Quality of Health Care | 4 | 2021 | 645 | 0.970 |
Why?
| | Self Care | 6 | 2012 | 387 | 0.960 |
Why?
| | Communication | 8 | 2025 | 941 | 0.960 |
Why?
| | Female | 85 | 2025 | 75814 | 0.960 |
Why?
| | Male | 83 | 2025 | 70140 | 0.950 |
Why?
| | Polypharmacology | 1 | 2025 | 2 | 0.930 |
Why?
| | Humans | 119 | 2025 | 141284 | 0.920 |
Why?
| | Mental Disorders | 6 | 2020 | 1133 | 0.840 |
Why?
| | Chronic Pain | 2 | 2022 | 281 | 0.830 |
Why?
| | Health Services | 2 | 2017 | 116 | 0.820 |
Why?
| | Caregivers | 13 | 2025 | 940 | 0.810 |
Why?
| | Benzodiazepines | 1 | 2024 | 162 | 0.800 |
Why?
| | Gastric Bypass | 2 | 2014 | 119 | 0.770 |
Why?
| | Attitude of Health Personnel | 5 | 2017 | 1178 | 0.750 |
Why?
| | Health Status Indicators | 2 | 2014 | 161 | 0.740 |
Why?
| | United States | 32 | 2025 | 15298 | 0.730 |
Why?
| | Qualitative Research | 14 | 2025 | 1519 | 0.720 |
Why?
| | Cholinergic Antagonists | 2 | 2019 | 24 | 0.700 |
Why?
| | Retrospective Studies | 30 | 2024 | 16447 | 0.690 |
Why?
| | Colorado | 17 | 2025 | 4599 | 0.670 |
Why?
| | Food Supply | 1 | 2021 | 90 | 0.660 |
Why?
| | Health Plan Implementation | 2 | 2019 | 142 | 0.660 |
Why?
| | Self Efficacy | 3 | 2019 | 404 | 0.640 |
Why?
| | Cohort Studies | 19 | 2025 | 5809 | 0.630 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 1039 | 0.610 |
Why?
| | Advance Directives | 1 | 2020 | 81 | 0.610 |
Why?
| | Patient Reported Outcome Measures | 4 | 2019 | 451 | 0.610 |
Why?
| | Medicare Part D | 2 | 2010 | 25 | 0.600 |
Why?
| | Mental Health Services | 3 | 2019 | 445 | 0.600 |
Why?
| | Hospitalization | 7 | 2024 | 2264 | 0.580 |
Why?
| | Middle Aged | 43 | 2025 | 34658 | 0.580 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1546 | 0.570 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 91 | 0.560 |
Why?
| | Telemedicine | 4 | 2024 | 893 | 0.560 |
Why?
| | Documentation | 1 | 2020 | 194 | 0.560 |
Why?
| | Health Services Needs and Demand | 3 | 2015 | 282 | 0.550 |
Why?
| | Diabetic Neuropathies | 2 | 2016 | 94 | 0.550 |
Why?
| | Hypolipidemic Agents | 3 | 2017 | 93 | 0.540 |
Why?
| | Specialization | 2 | 2017 | 130 | 0.530 |
Why?
| | Time-to-Treatment | 1 | 2018 | 224 | 0.510 |
Why?
| | Patient Acceptance of Health Care | 4 | 2021 | 874 | 0.500 |
Why?
| | Maryland | 4 | 2025 | 60 | 0.500 |
Why?
| | Health Maintenance Organizations | 6 | 2012 | 105 | 0.490 |
Why?
| | Medication Adherence | 4 | 2022 | 510 | 0.480 |
Why?
| | Medically Uninsured | 1 | 2017 | 135 | 0.480 |
Why?
| | Medicaid | 2 | 2022 | 450 | 0.480 |
Why?
| | Patient Satisfaction | 4 | 2019 | 695 | 0.480 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2023 | 2529 | 0.470 |
Why?
| | Practice Patterns, Physicians' | 3 | 2017 | 1336 | 0.470 |
Why?
| | Health Knowledge, Attitudes, Practice | 6 | 2021 | 1395 | 0.470 |
Why?
| | Adult | 35 | 2025 | 39319 | 0.470 |
Why?
| | Healthcare Disparities | 2 | 2021 | 674 | 0.470 |
Why?
| | Patients | 2 | 2021 | 179 | 0.470 |
Why?
| | Self Report | 6 | 2024 | 859 | 0.470 |
Why?
| | Health Promotion | 1 | 2021 | 749 | 0.450 |
Why?
| | Sickness Impact Profile | 2 | 2005 | 58 | 0.450 |
Why?
| | Antihypertensive Agents | 5 | 2019 | 508 | 0.450 |
Why?
| | Gastroplasty | 1 | 2014 | 32 | 0.440 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 99 | 0.430 |
Why?
| | Bariatric Surgery | 2 | 2015 | 220 | 0.430 |
Why?
| | Pain Management | 2 | 2015 | 397 | 0.430 |
Why?
| | Hypertension | 7 | 2019 | 1250 | 0.420 |
Why?
| | Hypoglycemic Agents | 5 | 2019 | 1380 | 0.410 |
Why?
| | Drug Utilization | 2 | 2012 | 166 | 0.410 |
Why?
| | Surveys and Questionnaires | 17 | 2022 | 5948 | 0.410 |
Why?
| | Diabetes Mellitus | 7 | 2017 | 1078 | 0.410 |
Why?
| | Neuralgia | 1 | 2015 | 142 | 0.400 |
Why?
| | Morbidity | 2 | 2012 | 320 | 0.400 |
Why?
| | Laparoscopy | 2 | 2014 | 465 | 0.390 |
Why?
| | Focus Groups | 5 | 2020 | 565 | 0.390 |
Why?
| | Sleep Deprivation | 1 | 2015 | 204 | 0.390 |
Why?
| | Postoperative Care | 1 | 2015 | 280 | 0.390 |
Why?
| | Socioeconomic Factors | 7 | 2020 | 1311 | 0.390 |
Why?
| | Comparative Effectiveness Research | 1 | 2014 | 163 | 0.380 |
Why?
| | Health Services Accessibility | 3 | 2017 | 1030 | 0.380 |
Why?
| | Preoperative Care | 1 | 2015 | 372 | 0.370 |
Why?
| | Morphine | 1 | 2013 | 166 | 0.370 |
Why?
| | Colorectal Neoplasms | 3 | 2014 | 811 | 0.370 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2012 | 48 | 0.360 |
Why?
| | Cross-Sectional Studies | 14 | 2023 | 5653 | 0.350 |
Why?
| | Osteoarthritis | 3 | 2008 | 202 | 0.350 |
Why?
| | Cluster Analysis | 2 | 2020 | 518 | 0.350 |
Why?
| | International Classification of Diseases | 1 | 2012 | 141 | 0.340 |
Why?
| | Referral and Consultation | 1 | 2017 | 802 | 0.340 |
Why?
| | Psychotherapy | 1 | 2012 | 186 | 0.340 |
Why?
| | Severity of Illness Index | 3 | 2015 | 2904 | 0.330 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 449 | 0.330 |
Why?
| | Office Visits | 3 | 2018 | 94 | 0.330 |
Why?
| | Antidepressive Agents | 1 | 2012 | 243 | 0.330 |
Why?
| | Obesity | 2 | 2014 | 3007 | 0.330 |
Why?
| | Prostatic Neoplasms | 2 | 2014 | 1050 | 0.320 |
Why?
| | Physician-Patient Relations | 6 | 2019 | 579 | 0.320 |
Why?
| | Quality Improvement | 5 | 2020 | 1241 | 0.310 |
Why?
| | Risk Assessment | 8 | 2024 | 3522 | 0.310 |
Why?
| | Models, Statistical | 1 | 2014 | 669 | 0.310 |
Why?
| | Patient Preference | 3 | 2022 | 204 | 0.310 |
Why?
| | Vaccination Refusal | 2 | 2021 | 70 | 0.310 |
Why?
| | Drug Monitoring | 2 | 2017 | 396 | 0.300 |
Why?
| | Multimorbidity | 2 | 2021 | 54 | 0.300 |
Why?
| | Patient Participation | 5 | 2022 | 427 | 0.300 |
Why?
| | Perception | 3 | 2020 | 375 | 0.300 |
Why?
| | Research | 3 | 2018 | 434 | 0.300 |
Why?
| | Stakeholder Participation | 2 | 2020 | 80 | 0.300 |
Why?
| | Neoplasms | 3 | 2014 | 2731 | 0.290 |
Why?
| | Medicare | 6 | 2023 | 802 | 0.280 |
Why?
| | Analgesics, Opioid | 2 | 2014 | 1117 | 0.280 |
Why?
| | Emergency Service, Hospital | 3 | 2015 | 2210 | 0.280 |
Why?
| | Health Services for the Aged | 1 | 2008 | 72 | 0.270 |
Why?
| | Health Personnel | 3 | 2019 | 727 | 0.270 |
Why?
| | Delphi Technique | 4 | 2018 | 314 | 0.270 |
Why?
| | Disease Progression | 2 | 2015 | 2808 | 0.260 |
Why?
| | Geriatrics | 1 | 2008 | 96 | 0.260 |
Why?
| | Cost of Illness | 2 | 2008 | 311 | 0.260 |
Why?
| | Glomerular Filtration Rate | 1 | 2011 | 755 | 0.260 |
Why?
| | Kidney Diseases | 1 | 2011 | 409 | 0.250 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2246 | 0.240 |
Why?
| | Psychometrics | 3 | 2018 | 736 | 0.240 |
Why?
| | Accidental Falls | 2 | 2019 | 215 | 0.240 |
Why?
| | Telephone | 2 | 2017 | 181 | 0.230 |
Why?
| | Pain Measurement | 2 | 2018 | 555 | 0.220 |
Why?
| | Disease Management | 4 | 2017 | 634 | 0.210 |
Why?
| | Nomograms | 2 | 2014 | 58 | 0.210 |
Why?
| | Needs Assessment | 2 | 2025 | 388 | 0.210 |
Why?
| | Single-Payer System | 1 | 2003 | 1 | 0.210 |
Why?
| | Patient Compliance | 1 | 2008 | 607 | 0.210 |
Why?
| | National Health Insurance, United States | 1 | 2003 | 4 | 0.210 |
Why?
| | Cardiovascular Diseases | 2 | 2014 | 2091 | 0.210 |
Why?
| | Managed Care Programs | 2 | 2014 | 140 | 0.210 |
Why?
| | Multivariate Analysis | 5 | 2013 | 1505 | 0.210 |
Why?
| | Parents | 3 | 2021 | 1439 | 0.210 |
Why?
| | Death | 2 | 2022 | 124 | 0.210 |
Why?
| | Dyslipidemias | 3 | 2019 | 177 | 0.210 |
Why?
| | Natural Language Processing | 1 | 2025 | 103 | 0.210 |
Why?
| | Pragmatic Clinical Trials as Topic | 2 | 2022 | 126 | 0.200 |
Why?
| | Health Services Research | 3 | 2017 | 401 | 0.200 |
Why?
| | Asthma | 2 | 2016 | 1911 | 0.190 |
Why?
| | Vaccination | 3 | 2021 | 1468 | 0.190 |
Why?
| | Interdisciplinary Communication | 2 | 2014 | 190 | 0.190 |
Why?
| | Insurance Coverage | 2 | 2018 | 239 | 0.190 |
Why?
| | Data Collection | 1 | 2005 | 655 | 0.190 |
Why?
| | Health Care Reform | 1 | 2003 | 109 | 0.190 |
Why?
| | Attitude | 2 | 2021 | 257 | 0.190 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2024 | 181 | 0.190 |
Why?
| | Prognosis | 4 | 2014 | 4080 | 0.190 |
Why?
| | Pharmacists | 1 | 2025 | 256 | 0.180 |
Why?
| | Physicians | 2 | 2023 | 930 | 0.180 |
Why?
| | Survival Rate | 3 | 2014 | 1979 | 0.180 |
Why?
| | Proxy | 1 | 2021 | 30 | 0.170 |
Why?
| | Interviews as Topic | 4 | 2024 | 839 | 0.170 |
Why?
| | Information Storage and Retrieval | 1 | 2021 | 118 | 0.160 |
Why?
| | Patient Care Management | 1 | 2020 | 55 | 0.160 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 169 | 0.160 |
Why?
| | Clergy | 1 | 2020 | 10 | 0.160 |
Why?
| | Age Factors | 6 | 2019 | 3295 | 0.160 |
Why?
| | Fee-for-Service Plans | 2 | 2014 | 88 | 0.160 |
Why?
| | Anti-Vaccination Movement | 1 | 2019 | 4 | 0.160 |
Why?
| | Longitudinal Studies | 4 | 2018 | 2929 | 0.160 |
Why?
| | California | 4 | 2025 | 457 | 0.160 |
Why?
| | Health Surveys | 3 | 2012 | 511 | 0.160 |
Why?
| | Southwestern United States | 1 | 2019 | 94 | 0.150 |
Why?
| | Urban Health Services | 1 | 2019 | 68 | 0.150 |
Why?
| | Religion | 1 | 2019 | 68 | 0.150 |
Why?
| | Follow-Up Studies | 4 | 2017 | 5222 | 0.150 |
Why?
| | Interprofessional Relations | 2 | 2013 | 282 | 0.150 |
Why?
| | Residence Characteristics | 1 | 2022 | 367 | 0.150 |
Why?
| | Sulfonylurea Compounds | 1 | 2019 | 50 | 0.150 |
Why?
| | Time Factors | 5 | 2018 | 6951 | 0.150 |
Why?
| | Attitude to Health | 2 | 2015 | 451 | 0.150 |
Why?
| | Child, Preschool | 5 | 2021 | 11511 | 0.140 |
Why?
| | Comprehensive Health Care | 2 | 2017 | 21 | 0.140 |
Why?
| | Contraindications, Drug | 1 | 2018 | 9 | 0.140 |
Why?
| | Research Design | 2 | 2024 | 1105 | 0.140 |
Why?
| | Medical Informatics | 1 | 2019 | 99 | 0.140 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2018 | 217 | 0.140 |
Why?
| | Vaccines | 2 | 2020 | 407 | 0.140 |
Why?
| | Mastectomy | 1 | 2018 | 152 | 0.140 |
Why?
| | Models, Theoretical | 1 | 2021 | 582 | 0.140 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 383 | 0.130 |
Why?
| | SEER Program | 2 | 2014 | 219 | 0.130 |
Why?
| | Independent Living | 1 | 2018 | 112 | 0.130 |
Why?
| | Prospective Studies | 5 | 2023 | 7805 | 0.130 |
Why?
| | Young Adult | 6 | 2016 | 13727 | 0.130 |
Why?
| | Blood Pressure | 3 | 2019 | 1740 | 0.130 |
Why?
| | Case Management | 1 | 2017 | 65 | 0.130 |
Why?
| | Electronics | 1 | 2017 | 74 | 0.120 |
Why?
| | General Practice | 1 | 2016 | 32 | 0.120 |
Why?
| | Logistic Models | 5 | 2013 | 2098 | 0.120 |
Why?
| | Schools | 1 | 2019 | 451 | 0.120 |
Why?
| | Medication Therapy Management | 1 | 2017 | 78 | 0.120 |
Why?
| | Influenza Vaccines | 1 | 2021 | 551 | 0.120 |
Why?
| | Patient Outcome Assessment | 1 | 2017 | 132 | 0.120 |
Why?
| | Validation Studies as Topic | 1 | 2015 | 22 | 0.120 |
Why?
| | Health Care Costs | 1 | 2019 | 417 | 0.120 |
Why?
| | Adolescent | 6 | 2015 | 22116 | 0.120 |
Why?
| | Body Mass Index | 2 | 2014 | 2390 | 0.120 |
Why?
| | Metformin | 1 | 2019 | 330 | 0.110 |
Why?
| | Risk Factors | 7 | 2024 | 10490 | 0.110 |
Why?
| | Influenza, Human | 1 | 2021 | 630 | 0.110 |
Why?
| | Clinical Decision-Making | 1 | 2018 | 341 | 0.110 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1397 | 0.110 |
Why?
| | Hyperlipidemias | 2 | 2012 | 126 | 0.110 |
Why?
| | Infant | 2 | 2021 | 9820 | 0.110 |
Why?
| | United States Agency for Healthcare Research and Quality | 1 | 2014 | 8 | 0.110 |
Why?
| | Proportional Hazards Models | 2 | 2015 | 1268 | 0.110 |
Why?
| | Health Priorities | 1 | 2014 | 42 | 0.100 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 863 | 0.100 |
Why?
| | Health Education | 1 | 2016 | 360 | 0.100 |
Why?
| | Child | 5 | 2021 | 22390 | 0.100 |
Why?
| | Age Distribution | 1 | 2014 | 396 | 0.100 |
Why?
| | Cooperative Behavior | 2 | 2014 | 456 | 0.100 |
Why?
| | Activities of Daily Living | 2 | 2008 | 429 | 0.100 |
Why?
| | Terminally Ill | 1 | 2013 | 37 | 0.100 |
Why?
| | Lung Diseases, Obstructive | 1 | 2012 | 43 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2017 | 560 | 0.090 |
Why?
| | Information Dissemination | 1 | 2014 | 209 | 0.090 |
Why?
| | Postoperative Period | 1 | 2013 | 359 | 0.090 |
Why?
| | Program Evaluation | 1 | 2017 | 919 | 0.090 |
Why?
| | Decision Making | 1 | 2019 | 949 | 0.090 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 319 | 0.090 |
Why?
| | Depression | 3 | 2018 | 1490 | 0.090 |
Why?
| | Secondary Prevention | 1 | 2013 | 241 | 0.090 |
Why?
| | Postoperative Complications | 2 | 2014 | 2831 | 0.090 |
Why?
| | Diabetes Complications | 1 | 2013 | 222 | 0.090 |
Why?
| | Primary Prevention | 1 | 2013 | 202 | 0.090 |
Why?
| | Obesity, Morbid | 1 | 2014 | 277 | 0.080 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 153 | 0.080 |
Why?
| | Data Mining | 1 | 2011 | 115 | 0.080 |
Why?
| | Insulin | 2 | 2019 | 2472 | 0.080 |
Why?
| | Pandemics | 3 | 2024 | 1655 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 717 | 0.080 |
Why?
| | Osteoarthritis, Knee | 1 | 2013 | 270 | 0.080 |
Why?
| | Weight Loss | 1 | 2015 | 794 | 0.080 |
Why?
| | Emigrants and Immigrants | 1 | 2012 | 148 | 0.080 |
Why?
| | Prescription Fees | 1 | 2008 | 4 | 0.070 |
Why?
| | Databases, Factual | 2 | 2012 | 1449 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3345 | 0.070 |
Why?
| | Medical Records Systems, Computerized | 2 | 2007 | 96 | 0.070 |
Why?
| | Poisson Distribution | 1 | 2008 | 76 | 0.070 |
Why?
| | Pain | 1 | 2014 | 779 | 0.070 |
Why?
| | Self Disclosure | 1 | 2008 | 65 | 0.070 |
Why?
| | Drug Utilization Review | 1 | 2008 | 61 | 0.070 |
Why?
| | Eligibility Determination | 1 | 2008 | 69 | 0.070 |
Why?
| | Community Health Services | 1 | 2010 | 232 | 0.070 |
Why?
| | Incidence | 2 | 2014 | 2809 | 0.070 |
Why?
| | Insurance, Pharmaceutical Services | 1 | 2007 | 24 | 0.070 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 463 | 0.070 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2013 | 372 | 0.070 |
Why?
| | Biomedical Research | 1 | 2014 | 684 | 0.070 |
Why?
| | Immunoglobulin G | 1 | 2012 | 882 | 0.070 |
Why?
| | Treatment Outcome | 4 | 2016 | 11216 | 0.070 |
Why?
| | Treatment Refusal | 1 | 2007 | 96 | 0.060 |
Why?
| | Sex Distribution | 1 | 2007 | 381 | 0.060 |
Why?
| | Odds Ratio | 3 | 2014 | 1057 | 0.060 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 716 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2023 | 3793 | 0.060 |
Why?
| | Opioid-Related Disorders | 1 | 2014 | 568 | 0.060 |
Why?
| | Urban Population | 2 | 2012 | 482 | 0.060 |
Why?
| | Linear Models | 1 | 2007 | 855 | 0.060 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1456 | 0.060 |
Why?
| | Chicago | 1 | 2004 | 62 | 0.050 |
Why?
| | Contraceptives, Oral | 1 | 2024 | 38 | 0.050 |
Why?
| | Los Angeles | 1 | 2004 | 75 | 0.050 |
Why?
| | Mass Screening | 1 | 2013 | 1309 | 0.050 |
Why?
| | Boston | 1 | 2004 | 91 | 0.050 |
Why?
| | Causality | 1 | 2024 | 131 | 0.050 |
Why?
| | Choice Behavior | 1 | 2005 | 171 | 0.050 |
Why?
| | Estrogen Replacement Therapy | 1 | 2024 | 142 | 0.050 |
Why?
| | Goals | 1 | 2005 | 177 | 0.050 |
Why?
| | Algorithms | 1 | 2011 | 1764 | 0.050 |
Why?
| | Self Concept | 1 | 2005 | 255 | 0.050 |
Why?
| | Social Support | 1 | 2007 | 629 | 0.050 |
Why?
| | Medicine | 1 | 2004 | 125 | 0.050 |
Why?
| | Regression Analysis | 1 | 2004 | 1013 | 0.050 |
Why?
| | Estrogens | 1 | 2024 | 371 | 0.040 |
Why?
| | Internet | 2 | 2019 | 683 | 0.040 |
Why?
| | Insurance Claim Review | 1 | 2021 | 85 | 0.040 |
Why?
| | Housing | 1 | 2022 | 146 | 0.040 |
Why?
| | Washington | 1 | 2021 | 159 | 0.040 |
Why?
| | Cholesterol, LDL | 2 | 2014 | 360 | 0.040 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 526 | 0.040 |
Why?
| | Self-Management | 1 | 2024 | 200 | 0.040 |
Why?
| | Health Expenditures | 1 | 2022 | 193 | 0.040 |
Why?
| | Medical Records | 1 | 2021 | 185 | 0.040 |
Why?
| | Assisted Living Facilities | 1 | 2020 | 17 | 0.040 |
Why?
| | Health Care Rationing | 1 | 2020 | 60 | 0.040 |
Why?
| | Resource Allocation | 1 | 2020 | 51 | 0.040 |
Why?
| | Minority Groups | 1 | 2022 | 278 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2020 | 132 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2096 | 0.040 |
Why?
| | Health Behavior | 1 | 2005 | 784 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1820 | 0.040 |
Why?
| | Medicare Part C | 1 | 2019 | 31 | 0.040 |
Why?
| | Nursing Homes | 1 | 2020 | 171 | 0.040 |
Why?
| | Stress, Psychological | 1 | 2007 | 1124 | 0.040 |
Why?
| | Appointments and Schedules | 1 | 2019 | 102 | 0.040 |
Why?
| | Mortality | 1 | 2020 | 359 | 0.030 |
Why?
| | Reference Values | 1 | 2019 | 803 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 296 | 0.030 |
Why?
| | Social Determinants of Health | 1 | 2021 | 275 | 0.030 |
Why?
| | Intention | 1 | 2019 | 180 | 0.030 |
Why?
| | Fatigue | 1 | 2018 | 342 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2019 | 1043 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2018 | 269 | 0.030 |
Why?
| | Automation | 1 | 2016 | 101 | 0.030 |
Why?
| | Drug Interactions | 1 | 2017 | 404 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 538 | 0.030 |
Why?
| | Hospitals | 1 | 2020 | 688 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2795 | 0.030 |
Why?
| | Sleep Wake Disorders | 1 | 2018 | 305 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 612 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2007 | 1312 | 0.030 |
Why?
| | Patient Access to Records | 1 | 2013 | 19 | 0.020 |
Why?
| | Electronic Mail | 1 | 2013 | 65 | 0.020 |
Why?
| | ROC Curve | 1 | 2014 | 594 | 0.020 |
Why?
| | Turkey | 1 | 2012 | 20 | 0.020 |
Why?
| | Forecasting | 1 | 2014 | 383 | 0.020 |
Why?
| | Etanercept | 1 | 2012 | 61 | 0.020 |
Why?
| | Remote Consultation | 1 | 2013 | 63 | 0.020 |
Why?
| | London | 1 | 2012 | 47 | 0.020 |
Why?
| | Mental Health | 1 | 2018 | 756 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2012 | 85 | 0.020 |
Why?
| | Infliximab | 1 | 2012 | 111 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2012 | 165 | 0.020 |
Why?
| | Biomarkers | 2 | 2013 | 4180 | 0.020 |
Why?
| | Anxiety | 1 | 2018 | 1078 | 0.020 |
Why?
| | United Kingdom | 1 | 2012 | 321 | 0.020 |
Why?
| | Reoperation | 1 | 2013 | 599 | 0.020 |
Why?
| | Immunologic Factors | 1 | 2012 | 249 | 0.020 |
Why?
| | Risk | 1 | 2012 | 903 | 0.020 |
Why?
| | Models, Organizational | 1 | 2010 | 143 | 0.020 |
Why?
| | Antirheumatic Agents | 1 | 2012 | 306 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2014 | 783 | 0.020 |
Why?
| | Aging | 1 | 2018 | 1919 | 0.020 |
Why?
| | Empathy | 1 | 2010 | 176 | 0.020 |
Why?
| | Patient Readmission | 1 | 2013 | 698 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1220 | 0.020 |
Why?
| | Holistic Health | 1 | 2007 | 15 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 2055 | 0.010 |
Why?
| | Learning | 1 | 2010 | 434 | 0.010 |
Why?
| | CD-ROM | 1 | 2005 | 5 | 0.010 |
Why?
| | Veterans | 1 | 2017 | 1519 | 0.010 |
Why?
| | Diet, Fat-Restricted | 1 | 2005 | 77 | 0.010 |
Why?
| | Computer-Assisted Instruction | 1 | 2005 | 68 | 0.010 |
Why?
| | Nonlinear Dynamics | 1 | 2005 | 92 | 0.010 |
Why?
| | Fruit | 1 | 2005 | 146 | 0.010 |
Why?
| | Vegetables | 1 | 2005 | 161 | 0.010 |
Why?
| | Patient Care Planning | 1 | 2005 | 156 | 0.010 |
Why?
| | Registries | 1 | 2012 | 2205 | 0.010 |
Why?
| | Patient Education as Topic | 1 | 2005 | 771 | 0.010 |
Why?
| | Exercise | 1 | 2005 | 2113 | 0.010 |
Why?
|
|
Bayliss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|